Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 79Leukemia, Myeloid, Acute 69Leukemia 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Myeloproliferative Disorders 38Leukemia, Myeloid, Accelerated Phase 36Leukemia, Myelomonocytic, Chronic 35Leukemia, Myeloid, Chronic-Phase 35Leukemia, Lymphocytic, Chronic, B-Cell 32Hodgkin Disease 32Congenital Abnormalities 32Blast Crisis 31Multiple Myeloma 30Lymphoma, Non-Hodgkin 29Graft vs Host Disease 29Lymphoma 28Primary Myelofibrosis 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Myelodysplastic-Myeloproliferative Diseases 23Lymphoma, Mantle-Cell 23Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 23Anemia, Refractory, with Excess of Blasts 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21Neoplasms, Plasma Cell 20Recurrence 15Leukemia, Myelomonocytic, Juvenile 15

Interventions

Therapeutics 5Flow Cytometry 5Polymerase Chain Reaction 3Methylprednisolone 3liposomal amphotericin B 2Psychiatric Rehabilitation 2Prednisone 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Immunoenzyme Techniques 2Dexamethasone 2Cyclophosphamide 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2thymoglobulin 1sargramostim 1ixabepilone 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1aldesleukin 1Voriconazole 1Valacyclovir 1Tacrolimus 1Sugars 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Methotrexate × Myeloid × Clear all
NCT00357084 2010-09-14

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
53 enrolled
DermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Neoplasms, Wilms Tumor, Recurrence, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡